High Tide Inc.
HITI • NASDAQ
High Tide Inc. is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Harkirat Grover, with a market cap of $198.6M.
CEOHarkirat Grover
Next Earnings
Upcoming earnings announcement for High Tide Inc.
Date
Monday, June 15, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.01
Revenue Estimate
$127.9M
Earnings History
Past 12 earnings reports for High Tide Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q1 2026 | $0.01Est: $0.01 | 0.0% | $127.9MEst: $127.2M | +0.6% | — |
| Jan 29, 2026 | Q4 2025 | $0.01Est: $0.01 | 0.0% | $117.6MEst: $115.2M | +2.1% | — |
| Sep 15, 2025 | Q3 2025 | $0.01Est: -$0.01 | +200.0% | $109.0MEst: $107.3M | +1.5% | — |
| Jun 16, 2025 | Q2 2025 | -$0.03Est: -$0.02 | -40.0% | $96.9MEst: $96.7M | +0.2% | — |
| Mar 17, 2025 | Q1 2025 | -$0.02Est: -$0.01 | -100.0% | $100.3MEst: $96.0M | +4.5% | — |
| Jan 29, 2025 | Q4 2024 | -$0.01Est: -$0.01 | 0.0% | $98.9MEst: $97.9M | +1.0% | — |
| Sep 16, 2024 | Q3 2024 | $0.01Est: -$0.02 | +150.0% | $96.2MEst: $94.4M | +1.9% | — |
| Jun 13, 2024 | Q2 2024 | $0.00Est: -$0.01 | +100.0% | $91.6MEst: $92.7M | -1.2% | — |
| Mar 15, 2024 | Q1 2024 | $0.00Est: -$0.01 | +100.0% | $94.1MEst: $94.7M | -0.6% | — |
| Jan 29, 2024 | Q4 2023 | $0.03Est: -$0.03 | +200.0% | $93.6MEst: $92.9M | +0.8% | — |
| Sep 14, 2023 | Q3 2023 | -$0.03Est: -$0.03 | 0.0% | $93.2MEst: $87.4M | +6.6% | — |
| Jun 14, 2023 | Q2 2023 | -$0.03Est: -$0.04 | +25.0% | $87.2MEst: $88.4M | -1.3% | — |